US Senate Confirms Indian-Origin Jay Bhattacharya NIH Director | NewsX
What this video covers
This NewsX segment reports the Senate’s confirmation of Dr. Jayanta “Jay” Bhattacharya as NIH director on March 25, 2025, by a 53-47 party-line vote in the 119th Congress. (The description’s “Jai” is a typo; his name is Jayanta.) The report, aimed at an Indian audience, presents the confirmation as a milestone for the Indian diaspora in American science leadership.
The vote made Bhattacharya director of the nation’s premier medical research agency, overseeing a budget of nearly $50 billion and funding for thousands of scientific projects. He was confirmed the same day as Marty Makary, who took the FDA on a 56-44 vote. Both men, per Reuters’ reporting, now report to Health Secretary Robert F. Kennedy Jr.
The immediate challenges awaiting him were substantial: legal battles over the Trump administration’s proposed cuts to federal research funding — a federal judge had blocked the indirect-cost cuts earlier that month — and the task of leading an agency whose leadership he had spent years criticizing. During his hearing he had pledged to prioritize chronic-disease research and to foster what he called a culture where “dissent is the very essence of science.”
Key points
- The Senate confirmed Bhattacharya 53-47 on March 25, 2025, along party lines.
- He succeeds Monica Bertagnolli as NIH director, overseeing roughly $50 billion in research funding.
- Marty Makary was confirmed the same day as FDA commissioner (56-44); both report to RFK Jr. at HHS.
- His first tests included court fights over federal research-funding cuts, which a judge had blocked weeks earlier.
- NewsX frames the appointment as a landmark for Indian-origin leadership in U.S. science.
- The segment does not dwell on the Great Barrington controversy that drew criticism from mainstream public-health experts during the nomination.